Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.

Current topics in medicinal chemistry

Volumn 2, Issue 2, 2002, Pages 113-132

  Blask, David E ^a   Sauer, Leonard A ^a   Dauchy, Robert T ^a  

^a BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MELATONIN;

ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; DRUG EFFECT; HUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIFFERENTIATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; HUMANS; MELATONIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0036479749     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026023394407     Document Type: Review

References (91)